Tisdale: Local Anesthetics Flashcards
MECHANISM OF ACTION
Normal Voltage Gated Sodium Channel Function
Sodium channels associated with:
Sodium channels associated with excitable membranes
MECHANISM OF ACTION
Normal Voltage Gated Sodium Channel Function
Exists in 3 conformations:
Exists in 3 conformations:
o Between impulses the channel is closed (resting; Na cannot enter)
o After stimulation (membrane depolarization) the channel is open (activated; Na enters)
o Transition from an open to closed conformation (inactive; Na cannot enter)
MECHANISM OF ACTION
Normal Voltage Gated Sodium Channel Function
After these events:
After these events, the membrane repolarizes and the channel reverts back to closed form
Local Anesthetic Mechanism of Action
Basics
Block:
Blockage prevents:
Block voltage-dependent Na channels associated with excitable membranes by reducing the influx of Na ions
Blockage prevents depolarization of the membrane and blocks conduction of the action potential
Local Anesthetic Mechanism of Action
Mechanism
Uncharged drug must:
Only ______ is pharmacologically active:
Uncharged drug must cross the nerve membrane to enter the cytoplasm, where it is re-protonated
Only the charged LA is pharmacologically active
Local Anesthetic Mechanism of Action
Mechanism
Charged LA binds:
Overall result:
Charged LA binds the receptor when the Na channel is in the open state, and stabilizes the inactive state
Overall result is blockade of Na current; if current is blocked over a critical length of the nerve, propagation across the blocked area is not possible
Structure OF LOCAL ANESTHETICS
General Properties
All LAs must contain:
Aromatic ring connected by:
pKa of most LAs between:
All LAs must contain an aromatic ring (lipophilic; increases potency and duration of action)
Aromatic ring connected by an intermediate chain via an ESTER or AMIDE bond to an ionizable group (ie. tertiary amine; gives water solubility to LAs)
pKa of most LAs between 7.8-9.0
Structure OF LOCAL ANESTHETICS
General Properties
pKa vs physiological pH:
Those with a pKa closest to physiological pH will have a higher concentration of nonionized base that can pass through the nerve cell membrane (more rapid onset)
LAs with moderate hydrophobiticity are the most clinically effective
Ester Containing LAs
Inactivated in the bloodstream by:
Patients with genetic abnormality:
termination of action depends on:
Overall:
Inactivated in the bloodstream by pseudocholinesterase (plasma cholinesterase or butyrylcholinesterase)
Patients that have genetic abnormality in this enzyme at increase risk for toxic side effects (slower metabolism)
CSF last esterase enzymes and therefore termination of action depends on absorption into the blood stream
Overall, shorter duration of action than amide LAs
Amide Containing LAs
Metabolized by:
Rate of metabolism depends on:
Metabolized by microsomal P450 enzymes in the liver (N-dealkylation or hydroxylation)
Rate of metabolism depends on the drug, but overall is much SLOWER than ester hydrolysis
Lidocaine > Mepivacaine > Ropivacaine > Bupivacaine
Amide Containing LAs
Decreases in hepatic function effects: (3)
Decreases in hepatic function or liver blood flow will reduce the metabolic rate (predispose to toxicity)
o Cirrhosis
o Congestive heart failure
o Vasopressors
Amide Containing LAs
Comparison in rates:
Lidocaine > Mepivacaine > Ropivacaine > Bupivacaine
Administration
Topical:
Infiltration:
Field Block:
Topical: anesthesia of the mucous membranes of the nose, mouth, throat, esophagus and genitourinary tract by direct application
Infiltration: injection of LA directly into tissue without considering course of cutaneous nerves (most common)
Field Block: subQ injection to anesthetize a region distal to the injection
Administration
Nerve Block:
Central Nerve Block:
Spinal:
Epidural:
Nerve Block: injection of LA into or around individual peripheral nerves or nerve plexuses
Central Nerve Block:
o Spinal: injection into the CSF in the lumbar space
o Epidural: injected into epidural space
Duration of Action:
Do NOT use where?
Examples:
Duration of Action:
- Limited unless blood flow to the area is reduced- administer with a vasoconstrictor (ie. EPI)
o Decrease rate of absorption and localize LA
o Rate LA destroyed=rate LA absorbed
Do NOT use in anatomical regions with limited collateral circulation (irreversible hypoxic damage, necrosis, gangrene)
o Examples: fingers, nose, penis, toes
Nerve Blockade
Differential Functional Blockade
Smaller type B and C fibers:
firing rate:
Smaller type B and C fibers (mediate pain) and small myelinated Type A delta fibers (pain and temperature) are blocked first
These sensory fibers have a HIGH firing rate and a long action potential duration, resulting in a more rapid blockade
Nerve Blockade
Differential Functional Blockade
Larger myelinated Types (3):
firing rate:
Larger myelinated Type Aα, Aβ and Aγ fibers (postural, touch, pressure and motor information) are blocked later
The motor fibers have a SLOW firing rate and a short action action potential duration, resulting in a slower blockade
Nerve Blockade
General Order of Functional Deficits after LA Administration:
General Order of Functional Deficits after LA Administration: pain, temperature, touch, pressure, motor fnc.
Nerve Blockade
Factors Affecting Rate of Block: (3)
Fiber diameter: smaller diameter results in faster block
Firing frequency: higher firing frequency results in faster block
Location in nerve bundle: those in the periphery of the bundle are blocked faster (exposed first and at higher concentrations)
Undesired Effects
CNS: (6)
o Stimulation (due to depression of cortical inhibitory pathways)
o Restlessness
o Dizzy
o Tremors
o Confusion
o Respiratory depression (main threat to life)
Undesired Effects
CV: (2)
o Myocardial depression (decreased electrical excitability, conduction rate and FOC)
o Some degree of arteriolar vasodilation (all LAs except cocaine cause smooth muscle relaxation)
Undesired Effects
Smooth Muscle: (2)
o Depress contractions in GI tract
o Relax vascular and bronchial smooth muscle
Undesired Effects
Hypersensitivity: (2)
More likely with:
o Allergic dermatitis
o Asthma
o More likely with esters because they are derivatives of PABA (known allergen)
Cocaine
General:
Duration/Onset:
General: first local anesthetic
Duration/Onset: medium onset and medium duration
Cocaine
Effects: (2)
Effects:
o Local anesthetic and CNS stimulant properties
o Potent vascoconstrictor
Cocaine
Toxicity: (2)
Clinical Use:
Toxicity:
o CNS toxicity related to both local anesthetic properties AND influence on re-uptake of catecholamines
o Impaired reuptake associated with adrenergic phenomena (HTN, increase HR, arrhythmia, and other serious cardiac effecs)
Clinical Use: anesthesia of mucous membranes
Procaine (Novocaine)
General:
Onset:
Anesthesia in _____ minutes
General: first synthetic anesthetic
Onset: slow onset (pka=8.9; the higher the pKa, the lower the concentration in membrane permeable form)
o Anesthesia in 2-5 minutes
Procaine (Novocaine)
Duration:
Metabolism:
Clinical Use:
Duration: short duration (low hydrophobicity and therefore rapidly dissociates from the Na channel)
o Drug is not retained in tissue (rapid removal from site via the circulation)
Metabolism: hydrolyzed to PABA (be aware of allergy and interaction with sulfa drugs)
Clinical Use: infiltration and dental procedures
Benzocaine
Potency:
Onset:
Duration:
Potency: low
Onset: rapid (initial effects obtained in 1 minute)
Duration: short-acting (effects last about 15-20 minutes)
Benzocaine
Unique Mechanism:
Forms:
Unique Mechanism: stabilizes the CLOSED form of the Na channel (small/fits into the pore in the closed state)
Forms: cream, aerosol, ointment
Benzocaine
Clinical Use: (3)
Clinical Use:
o Topical pain reliever
o Anesthesia of mucous membranes
o Insertion of medical devices
Tetracaine
Potency:
Duration:
Potency: high
Duration: long duration of action (high hydrophobicity due to butyl group)
o Prolonged interaction with the Na channel
o Increased time associated with tissue surrounding the nerve
Tetracaine
Toxicity:
Clinical Use:
Toxicity: may result due to the fact that it is more slowly metabolized than other ester LAs (released gradually from tissue into blood)
Clinical Use: spinal and topical anesthesia
ESTER-DERIVED LOCAL ANESTHETICS: (4)
Cocaine
Procaine
Benzocaine
Tetracaine
AMIDE-CONTAINING LOCAL ANESTHETICS: (3)
Lidocaine
Bupivacaine
Ropivacaine
Lidocaine
General:
Onset:
General: prototype amide linked drug and most widely used
Onset: rapid (lowest pKa of all the LAs we learn)
Lidocaine
Potency:
Duration:
Forms:
Potency: moderate
Duration: medium-long duration (1-2 hours) o Moderate hydrophobicity o Metabolites (from metabolism in the liver) retain some anesthetic activity
Forms: ointment, jelly, patch, aerosol, solution
Lidocaine
Clinical Use: (5)
o Infiltration o Nerve block o Epidural o Spinal anesthesia o Topical anesthesia
Bupivacaine
Potency:
Duration:
Hydrophobic/philic?
Potency: good
Duration: prolonged anesthesia (up to 16 hours)
- Highly hydrophobic (butyl piperidine group attached to tertiary N)
Bupivacaine
Selective block:
Toxicities:
Selective block: more sensory than motor block (if you give a dilute solution)
Toxicities: cardiotoxic properties
Bupivacaine
Clinical Use: (4)
o Epidural*
o Infiltration
o Nerve block
o Spinal anesthesia
Ropivacaine
General:
Positive Features: ( 4)
General: newest amide LA; very similar to bupivacaine
Positive Features: o Low cardiotoxicity o Less lipid soluble o Preferentially blocks sensory neurons o Produces vasoconstriction itself (do not need to add EPI)
Ropivacaine
Clinical Use: (3)
o Epidural
o Infiltration
o Nerve block
Benzocaine
Potency:
pKa:
Parenteral Uses:
Topical Uses:
Low
No amine group
None
Dermal
Laryngeal
Oral
Cocaine
Potency:
pKa:
Parenteral Uses:
Topical Uses:
Low
8.7
None
Nose
Mouth/throat
Ear
Procaine
Potency:
pKa:
Parenteral Uses:
Topical Uses:
Low
8.9
Infiltration
Nerve block
Spinal
None
Tetracaine
Potency:
pKa:
Parenteral Uses:
Topical Uses:
High
8.2
Spinal
Larynx
Trachea
Esophagus
Lidocaine
Potency:
pKa:
Parenteral Uses:
Topical Uses:
Intermediate
7.8
Epidural
Infiltration
Nerve block
Spinal
Dermal
Laryngeal
Oral
Bupivacaine
Potency:
pKa:
Parenteral Uses:
Topical Uses:
High
8.1
Epidural
Infiltration
Nerve block
Spinal
None
Ropivacaine
Potency:
pKa:
Parenteral Uses:
Topical Uses:
High
8.1
Epidural
Infiltration
Nerve block
None